Genomic deletions in African swine fever vaccines that enable efficient growth in stable cell lines

JP7703030B2Active Publication Date: 2025-07-04US SEC AGRI
2 Cites 0 Cited by

Patent Information

Application Number
JP2023537619
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2020-12-22
Filing Date
2021-03-25
Publication Date
2025-07-04
Estimated Expiration
2041-03-25

Smart Images

  • Figure 0007703030000003
    Figure 0007703030000003
  • Figure 0007703030000004
    Figure 0007703030000004
  • Figure 0007703030000005
    Figure 0007703030000005
Patent Text Reader

Abstract

Details are provided regarding the construction of a recombinant live attenuated African swine fever virus (ASFV) vaccine for the prevention of ASF caused by various strains of ASFV, such as the highly pathogenic Georgia 2007 isolate ("ASFV-G"). An exemplary vaccine contains multiple gene deletions that permit industrial-scale growth in stable cell lines.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • African swine fever virus georgia strain adapted to efficiently grow in the vero cell line

    US9474797B1

  • Attenuated african swine fever virus vaccine

    WO2015193685A1